{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-015192","form_type":"8-K","ticker":"RNXT","cik":"0001574094","company_name":"RenovoRx, Inc.","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.037027+00:00","generated_at":"2026-06-03T18:53:39.088194+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"RenovoRx regains Nasdaq compliance after $17.2M fundraising; hearing cancelled","bullets":["Nasdaq confirmed RenovoRx met $2.5M minimum stockholders' equity requirement; prior deficiency remedied.","Company raised $17.2M in gross proceeds in 2024, extending cash runway into 2026.","Hearing before Nasdaq Hearings Panel cancelled; no ongoing monitor required.","Management to focus on Phase III TIGeR-PaC trial progress, TAMP pipeline expansion, and business development."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-015192","json":"https://secwatch.observer/filing/0001493152-24-015192.json","markdown":"https://secwatch.observer/filing/0001493152-24-015192.md","text":"https://secwatch.observer/filing/0001493152-24-015192.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574094/000149315224015192/0001493152-24-015192-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574094/000149315224015192/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T18:53:39.088194+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}